Published on January 26, 2026

Share:

Input From the Horse Industry Needed to Support USDA Study 

We need your help! We need equine industry stakeholders to submit comments sharing why the NAHMS Equine study is critical to the horse industry.

 The NAHMS Equine Study is a U.S. Department of Agriculture (USDA) initiative under the National Animal Health Monitoring System (NAHMS) that conducts periodic, comprehensive health and management assessments of the nation's equine population, with the next study, Equine 2026, focusing on biosecurity, health management, and major industry concerns like EHV, through surveys of randomly selected farms and events.

 These non-regulatory studies provide vital data for horse owners, veterinarians, and industry stakeholders to address health gaps and improve welfare. USDA is soliciting comments on the 2026 NAHMS Equine Study.

 The NAHMS Equine Study gathers information from many facets of the industry regarding equine health and wellness. This data is critical to supporting industry knowledge of gaps in supporting good biosecurity and welfare, USDA and industry disease preparedness and prevention, and supports industry education for owners. We’ve attached the letter we’ve submitted, but encourage you to submit unique comments that include:

  • Why knowledge and research into biosecurity, husbandry, and welfare practices is important to you
  • Why data to support industry disease preparedness and prevention is important to you
  • If you actively use the NAHMS data reports and how you use them
  • Why continuing to delay the NAHMS Equine Study is detrimental to your part of the industry

 Long letters aren’t necessary, and we’re happy to help you write and submit a letter of your own.

 You can view previous NAHMS data reports and learn more about the NAHMS Equine studies here:https://www.aphis.usda.gov/livestock-poultry-disease/nahms/equine

 Comments are due Feb. 11 and can be submitted here: Public Comment

 Thank you for your support in this matter, we’re here for any questions you have, please reach out to [email protected]